Skip to main content
. 2020 Oct 6;29(12):1755–1762. doi: 10.1007/s10068-020-00829-0

Table 3.

Objective sleep parameters analyzed by EEG under the onion extract and placebo conditions

Evaluated factor Before (n = 18) Onion extract Placebo
Amount of change (n = 18) Amount of change (n = 18)
Total sleep time Min 333.9 ± 15.0 0.9 ± 21.7 − 19.7 ± 17.0
Sleep period time Min 369.5 ± 17.0 12.6 ± 27.0 − 20.8 ± 18.9
During REM sleep latency Min 70.3 ± 5.7 6.1 ± 9.3 − 3.8 ± 7.5
Sleep latency Min 35.6 ± 11.4 − 0.1 ± 8.1* 15.3 ± 10.5

The total time of NREM sleep stage1

(the ratio of NREM sleep stage1)

Min

(%)

48.7

(13.4)

±

4.0

(1.1)

7.8

(1.0)

±

9.2

(1.4)

1.1

(1.5)

±

5.0

(1.7)

The total time of NREM sleep stage2

(the ratio of NREM sleep stage2)

Min

(%)

189.6

(51.2)

±

10.2

(1.8)

− 8.5

(− 3.2)

±

13.3

(1.8)

− 18.4

(− 2.4)

±

13.2

(2.3)

The total time of NREM sleep stage3

(the ratio of NREM sleep stage3)

Min

(%)

14.0

(4.0)

±

3.6

(1.0)

2.5

(0.6)

±

2.7

(1.0)

− 2.7

(− 0.9)

±

2.1

(0.5)

The total time of NREM sleep stage 1–3

(the ratio of NREM sleep stage 1–3)

Min

(%)

252.4

(68.6)

±

11.7

(1.4)

1.8

(− 1.5)

±

18.0

(1.4)

− 20.0

(− 1.8)

±

14.3

(1.3)

The total time of REM sleep

(the ratio of REM sleep)

Min

(%)

81.5

(21.9)

±

5.9

(1.2)

− 0.9

(− 0.8)

±

6.7

(1.5)

0.3

(1.6)

±

5.6

(1.4)

Awaking index Times 11.4 ± 1.1 2.7 ± 1.1* 0.2 ± 1.0
Wake after sleep onset (WASO) Min 35.6 ± 4.4 11.6 ± 6.9* − 1.1 ± 4.1
Sleep efficiency % 80.9 ± 2.9 − 2.1 ± 3.4 − 1.8 ± 2.3
Delta power during first NREM μV2 96270.1 ± 10609.4 14323.4 ± 8307.1* − 19564.8 ± 11231.7
Delta power during first NREM/min μV2/min 1495.6 ± 144.9 126.2 ± 107.1* − 186.9 ± 168.4
Delta power during NREM μV2 269253.8 ± 29710.7 23817.1 ± 27443.6* − 47071.9 ± 24713.5
Delta power during NREM/min μV2/min 1068.6 ± 105.7 106.8 ± 103.8* − 127.4 ± 81.7

Each value compared before and after treatment

EEG: electroencephalogram, REM: rapid-eye movement, NREM: non-rapid eye movement

All values are expressed as mean ± SE. *Intergroup comparison (p < 0.05, vs. placebo group)